<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(2)</volume><submitter>Lee HJ</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to clarify the sex differences in various cardiovascular and non-cardiovascular outcomes, and to investigate whether sex differences in outcomes are affected by age in hypertrophic cardiomyopathy (HCM).&lt;h4>Methods&lt;/h4>A cohort of 835 patients with HCM initially evaluated during 2007-2019 were followed for a median of 6.4 years. Study outcomes were all-cause death, cardiovascular and non-cardiovascular death, sudden cardiac death (SCD)/SCD equivalent events, heart failure (HF) events, and the composite cardiovascular outcome including cardiovascular death, SCD/SCD equivalent events, admission for HF, and heart transplantation.&lt;h4>Results&lt;/h4>Women were 5 years older (women 59.9±13.5 vs. men 54.9±11.4 years), had worse dyspnea, and greater left ventricular (LV) di</pubmed_abstract><journal>PloS one</journal><pagination>e0264580</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8880392</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.</pubmed_title><pmcid>PMC8880392</pmcid><pubmed_authors>Kim HK</pubmed_authors><pubmed_authors>Ommen SR</pubmed_authors><pubmed_authors>Chang SA</pubmed_authors><pubmed_authors>Choi YJ</pubmed_authors><pubmed_authors>Kim YJ</pubmed_authors><pubmed_authors>Lee SC</pubmed_authors><pubmed_authors>Lee HJ</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Park JB</pubmed_authors><pubmed_authors>Lee SP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.</name><description>&lt;h4>Background&lt;/h4>We aimed to clarify the sex differences in various cardiovascular and non-cardiovascular outcomes, and to investigate whether sex differences in outcomes are affected by age in hypertrophic cardiomyopathy (HCM).&lt;h4>Methods&lt;/h4>A cohort of 835 patients with HCM initially evaluated during 2007-2019 were followed for a median of 6.4 years. Study outcomes were all-cause death, cardiovascular and non-cardiovascular death, sudden cardiac death (SCD)/SCD equivalent events, heart failure (HF) events, and the composite cardiovascular outcome including cardiovascular death, SCD/SCD equivalent events, admission for HF, and heart transplantation.&lt;h4>Results&lt;/h4>Women were 5 years older (women 59.9±13.5 vs. men 54.9±11.4 years), had worse dyspnea, and greater left ventricular (LV) di</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T08:58:29.975Z</modification><creation>2025-04-04T08:58:29.975Z</creation></dates><accession>S-EPMC8880392</accession><cross_references><pubmed>35213653</pubmed><doi>10.1371/journal.pone.0264580</doi></cross_references></HashMap>